|
Contemporary Amperex Technology Co., Limited (300750.SZ) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Contemporary Amperex Technology Co., Limited (300750.SZ) Bundle
Simplify Contemporary Amperex Technology Co., Limited (300750SZ) valuation with this customizable DCF Calculator! Featuring real Contemporary Amperex Technology Co., Limited (300750SZ) financials and adjustable forecast inputs, you can test scenarios and uncover Contemporary Amperex Technology Co., Limited (300750SZ) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50,319.5 | 130,355.8 | 328,594.0 | 400,917.0 | 362,012.6 | 355,943.5 | 349,976.3 | 344,109.0 | 338,340.1 | 332,668.0 |
| Revenue Growth, % | 0 | 159.06 | 152.07 | 22.01 | -9.7 | -1.68 | -1.68 | -1.68 | -1.68 | -1.68 |
| EBITDA | 12,518.5 | 27,010.7 | 49,660.9 | 76,629.9 | 90,208.7 | 74,566.1 | 73,316.1 | 72,086.9 | 70,878.4 | 69,690.2 |
| EBITDA, % | 24.88 | 20.72 | 15.11 | 19.11 | 24.92 | 20.95 | 20.95 | 20.95 | 20.95 | 20.95 |
| Depreciation | 4,867.9 | 6,436.6 | 13,252.5 | 22,646.0 | 23,147.5 | 21,846.0 | 21,479.8 | 21,119.7 | 20,765.6 | 20,417.5 |
| Depreciation, % | 9.67 | 4.94 | 4.03 | 5.65 | 6.39 | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 |
| EBIT | 7,650.6 | 20,574.1 | 36,408.3 | 53,983.9 | 67,061.1 | 52,720.1 | 51,836.3 | 50,967.3 | 50,112.8 | 49,272.7 |
| EBIT, % | 15.2 | 15.78 | 11.08 | 13.47 | 18.52 | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 |
| Total Cash | 71,712.2 | 90,435.9 | 193,024.7 | 264,314.3 | 317,794.2 | 271,821.0 | 267,264.0 | 262,783.4 | 258,377.9 | 254,046.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 21,327.5 | 31,982.7 | 81,036.9 | 121,352.4 | 120,183.2 | 110,376.8 | 108,526.3 | 106,706.9 | 104,918.0 | 103,159.1 |
| Account Receivables, % | 42.38 | 24.53 | 24.66 | 30.27 | 33.2 | 31.01 | 31.01 | 31.01 | 31.01 | 31.01 |
| Inventories | 13,224.6 | 40,199.7 | 76,668.9 | 45,433.9 | 59,835.5 | 77,106.8 | 75,814.1 | 74,543.1 | 73,293.5 | 72,064.7 |
| Inventories, % | 26.28 | 30.84 | 23.33 | 11.33 | 16.53 | 21.66 | 21.66 | 21.66 | 21.66 | 21.66 |
| Accounts Payable | 15,634.8 | 48,784.3 | 94,535.0 | 127,160.2 | 198,333.7 | 130,822.3 | 128,629.2 | 126,472.7 | 124,352.5 | 122,267.7 |
| Accounts Payable, % | 31.07 | 37.42 | 28.77 | 31.72 | 54.79 | 36.75 | 36.75 | 36.75 | 36.75 | 36.75 |
| Capital Expenditure | -13,302.4 | -43,767.8 | -48,215.3 | -33,624.9 | -31,179.9 | -65,269.1 | -64,174.8 | -63,099.0 | -62,041.1 | -61,001.0 |
| Capital Expenditure, % | -26.44 | -33.58 | -14.67 | -8.39 | -8.61 | -18.34 | -18.34 | -18.34 | -18.34 | -18.34 |
| Tax Rate, % | 19.68 | 19.68 | 19.68 | 19.68 | 19.68 | 19.68 | 19.68 | 19.68 | 19.68 | 19.68 |
| EBITAT | 6,117.5 | 16,481.7 | 30,507.5 | 44,178.4 | 53,860.2 | 42,810.2 | 42,092.5 | 41,386.8 | 40,693.0 | 40,010.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21,234.2 | -25,330.3 | -44,227.9 | 56,744.3 | 103,768.8 | -75,589.1 | 347.3 | 341.5 | 335.8 | 330.2 |
| WACC, % | 8.35 | 8.35 | 8.36 | 8.35 | 8.35 | 8.35 | 8.35 | 8.35 | 8.35 | 8.35 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -68,733.5 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 343 | |||||||||
| Terminal Value | 7,890 | |||||||||
| Present Terminal Value | 5,283 | |||||||||
| Enterprise Value | -63,450 | |||||||||
| Net Debt | -189,992 | |||||||||
| Equity Value | 126,542 | |||||||||
| Diluted Shares Outstanding, MM | 4,380 | |||||||||
| Equity Value Per Share | 28.89 |
Benefits You Will Receive
- Comprehensive Financial Model: Utilize Contemporary Amperex Technology Co., Limited's actual data for accurate DCF valuation.
- Enhanced Forecast Flexibility: Modify revenue growth rates, profit margins, WACC, and other critical factors.
- Real-Time Updates: Automatic recalculations ensure you see immediate results as you adjust parameters.
- Professional-Grade Template: A polished Excel file crafted for top-tier valuation analyses.
- Customizable and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasting.
Main Highlights
- Customizable Forecast Settings: Adjust essential factors such as revenue growth, EBITDA percentage, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and additional metrics in real-time.
- Professional-Grade Precision: Leverages Contemporary Amperex Technology Co., Limited's (300750SZ) actual financial data for accurate valuation results.
- Streamlined Scenario Analysis: Effortlessly evaluate different assumptions and analyze varying outcomes.
- Efficient Tool: Remove the hassle of developing intricate valuation models from the ground up.
How It Works
- Download: Obtain the user-friendly Excel file featuring Contemporary Amperex Technology Co., Limited's (300750SZ) financial data.
- Customize: Tailor forecasts, including revenue growth, EBITDA %, and WACC to meet your analysis needs.
- Update Automatically: Enjoy real-time updates on intrinsic value and NPV calculations.
- Test Scenarios: Generate various projections and instantly compare outcomes for better insights.
- Make Decisions: Leverage the valuation results to inform your investment approach for Contemporary Amperex Technology Co., Limited (300750SZ).
Why Opt for This Calculator from Contemporary Amperex Technology Co., Limited (300750SZ)?
- Time-Saving: Skip the hassle of building a DCF model from the ground up – it’s ready for immediate use.
- Enhanced Accuracy: Dependable financial data and formulas minimize valuation errors.
- Completely Customizable: Adjust the model to align with your specific assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs simplify result analysis.
- Endorsed by Professionals: Crafted for experts who prioritize precision and functionality.
Who Can Benefit from This Product?
- Investors: Empower yourself to make informed decisions with a cutting-edge valuation tool.
- Financial Analysts: Streamline your workflow with a customizable DCF model that's ready to go.
- Consultants: Effortlessly tailor the template for client reports and presentations.
- Finance Enthusiasts: Enhance your grasp of valuation methods through real-life scenarios.
- Educators and Students: Utilize it as a hands-on resource in finance courses.
What the Template Contains
- Preloaded CATL Data: Historical and projected financial information, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financials for in-depth analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to assess performance.
- Dashboard and Charts: Visual overviews of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.